[go: up one dir, main page]

CN110759905A - 9S-acyloxy cinchonine derivative, preparation method and application thereof, and botanical pesticide - Google Patents

9S-acyloxy cinchonine derivative, preparation method and application thereof, and botanical pesticide Download PDF

Info

Publication number
CN110759905A
CN110759905A CN201911001699.2A CN201911001699A CN110759905A CN 110759905 A CN110759905 A CN 110759905A CN 201911001699 A CN201911001699 A CN 201911001699A CN 110759905 A CN110759905 A CN 110759905A
Authority
CN
China
Prior art keywords
acyloxycinchonine
carbon atoms
cinchonine
derivatives
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911001699.2A
Other languages
Chinese (zh)
Other versions
CN110759905B (en
Inventor
车志平
田月娥
夏彦飞
刘圣明
陈根强
林晓民
孙迪
杨进明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan University of Science and Technology
Original Assignee
Henan University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University of Science and Technology filed Critical Henan University of Science and Technology
Priority to CN201911001699.2A priority Critical patent/CN110759905B/en
Publication of CN110759905A publication Critical patent/CN110759905A/en
Application granted granted Critical
Publication of CN110759905B publication Critical patent/CN110759905B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于杂环化合物技术领域,具体涉及一种9S‑酰氧基辛可宁类衍生物及其制备方法和应用,还涉及一种植物源杀虫剂。本发明的9S‑酰氧基辛可宁类衍生物,其结构式为:

Figure DDA0002241523910000011
其中,R选自烷基、苯亚烷基、萘亚烷基、苯基、取代苯基中的任一种;所述烷基中的碳原子个数为1~5;所述苯亚烷基、萘亚烷基中亚烷基的碳原子个数为1~4;所述取代苯基中的取代基为卤素、硝基、烷氧基、碳原子个数为1~4的烷基中的一种或多种,所述烷氧基中的碳原子个数为1~3。本发明的9S‑酰氧基辛可宁类衍生物具有较好的杀虫活性,其中大部分衍生物的杀虫效果已超过商品化的植物源杀虫剂川楝素,具有较好的应用前景,为植物源农药的开发提供了新的方向。

Figure 201911001699

The invention belongs to the technical field of heterocyclic compounds, in particular to a 9S-acyloxycinchonine derivative, a preparation method and application thereof, and a botanical insecticide. 9S-acyloxycinchonine derivatives of the present invention, its structural formula is:

Figure DDA0002241523910000011
Wherein, R is selected from any one of alkyl, phenylalkylene, naphthylene, phenyl, and substituted phenyl; the number of carbon atoms in the alkyl is 1 to 5; the phenylene The number of carbon atoms in the alkylene group is 1 to 4; the substituents in the substituted phenyl group are halogen, nitro, alkoxy, and alkyl with 1 to 4 carbon atoms. One or more of the alkoxy groups, the number of carbon atoms in the alkoxy group is 1-3. The 9S-acyloxycinchonine derivatives of the present invention have good insecticidal activity, and the insecticidal effect of most of the derivatives has exceeded the commercial plant-derived insecticide toosendanin, and has good application prospects, It provides a new direction for the development of botanical pesticides.

Figure 201911001699

Description

一种9S-酰氧基辛可宁类衍生物及其制备方法和应用,植物源 杀虫剂A kind of 9S-acyloxycinchonine derivatives and preparation method and application thereof, plant source Insecticide

技术领域technical field

本发明属于杂环化合物技术领域,具体涉及一种9S-酰氧基辛可宁类衍生物及其制备方法和应用,还涉及一种植物源杀虫剂。The invention belongs to the technical field of heterocyclic compounds, in particular to a 9S-acyloxycinchonine derivative, a preparation method and application thereof, and a botanical insecticide.

背景技术Background technique

研究表明,黄金鸡纳树(C.calisaya)的根和茎对甜瓜绢野螟(DiaphaniahyalinataL.)和小菜蛾(PlutellaxylostellaL.)有毒杀作用;药金鸡纳树(C.officinalis)对织网衣蛾(TineapellionellaL.)有驱避作用;红金鸡纳树(C.pubescens)的茎皮也能驱蛾(徐汉虹,杀虫植物与植物性杀虫剂,中国农业出版社,北京:2000,49-50)。因此金鸡纳树中应具有能够杀虫或驱虫的活性成分,已有研究表明金鸡纳树中的奎宁具有一定的杀虫活性(《奎宁类化合物研究进展》,车志平等,化学通报,2018,81(9):792-796)。Studies have shown that the roots and stems of C.calisaya are toxic to melon moth (Diaphaniahyalinata L.) and diamondback moth (Plutellaxylostella L.); (Tineapellionella L.) has repellent effect; the stem bark of C. pubescens can also repel moths (Xu Hanhong, Insecticidal Plants and Botanical Insecticides, China Agricultural Press, Beijing: 2000, 49-50 ). Therefore, the cinchona tree should have active ingredients that can kill or repel insects. Studies have shown that the quinine in the cinchona tree has certain insecticidal activity ("Research Progress on Quinine Compounds", Che Zhiping, Chemical Bulletin , 2018, 81(9):792-796).

辛可宁是金鸡纳树次生代谢产物之一,其分子式为C19H22N2O,结构式为Cinchonine is one of the secondary metabolites of cinchona tree, its molecular formula is C 19 H 22 N 2 O, and its structural formula is

Figure BDA0002241523890000011
Figure BDA0002241523890000011

目前,关于辛可宁的研究主要集中在不对称合成以及手性催化领域,对于辛可宁以及辛可宁类衍生物在杀虫方面的研究未见报道。At present, the research on cinchonine mainly focuses on the fields of asymmetric synthesis and chiral catalysis, and there is no report on the research on the insecticidal aspects of cinchonine and its derivatives.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种9S-酰氧基辛可宁类衍生物,该类衍生物具有杀虫活性。The object of the present invention is to provide a 9S-acyloxycinchonine derivative, which has insecticidal activity.

本发明的目的还在于提供一种上述9S-酰氧基辛可宁类衍生物的制备方法。Another object of the present invention is to provide a method for preparing the above-mentioned 9S-acyloxycinchonine derivatives.

本发明的目的还在于提供一种辛可宁以及上述9S-酰氧基辛可宁类衍生物在防治鳞翅目虫害方面的应用。The present invention also aims to provide a kind of cinchonine and the application of the above-mentioned 9S-acyloxycinchonine derivatives in preventing and controlling lepidopteran pests.

本发明的目的还在于提供一种植物源杀虫剂,具有较好的杀虫活性。The present invention also aims to provide a botanical insecticide with better insecticidal activity.

为实现上述目的,本发明的9S-酰氧基辛可宁类衍生物采用的技术方案为:For achieving the above object, the technical scheme adopted by the 9S-acyloxycinchonine derivatives of the present invention is:

一种9S-酰氧基辛可宁类衍生物,其结构式为:A 9S-acyloxycinchonine derivative, its structural formula is:

其中,R选自烷基、苯亚烷基、萘亚烷基、苯基、取代苯基中的任一种;所述烷基中的碳原子个数为1~5;所述苯亚烷基、萘亚烷基中亚烷基的碳原子个数为1~4;所述取代苯基中的取代基为卤素、硝基、烷氧基、碳原子个数为1~4的烷基中的一种或多种,所述烷氧基中的碳原子个数为1~3。Wherein, R is selected from any one of alkyl, phenylalkylene, naphthylene, phenyl, and substituted phenyl; the number of carbon atoms in the alkyl is 1 to 5; the phenylene The number of carbon atoms in the alkylene group is 1 to 4; the substituents in the substituted phenyl group are halogen, nitro, alkoxy, and alkyl with 1 to 4 carbon atoms. One or more of the alkoxy groups, the number of carbon atoms in the alkoxy group is 1-3.

其中烷基为链状烷基,优选为不含支链的直链烷基。Wherein the alkyl group is a chain alkyl group, preferably a straight chain alkyl group without branching.

优选的,R选自甲基、戊基、苯亚甲基、萘亚甲基、苯基、取代苯基中的任一种;所述取代苯基中的取代基为氯、溴、硝基、甲氧基、甲基、丁基中的一种或多种。Preferably, R is selected from any one of methyl, pentyl, benzylidene, naphthylmethylene, phenyl, and substituted phenyl; the substituent in the substituted phenyl is chlorine, bromine, nitro , one or more of methoxy, methyl and butyl.

优选的,R选自甲基、正戊基、萘亚甲基、苯亚甲基、3-甲基苯基、4-甲基苯基、4-甲氧基苯基、4-叔丁基苯基、4-氯苯基、4-溴苯基、3-硝基苯基、4-硝基苯基中的任意一种。其中3-甲基苯基、4-甲基苯基、4-甲氧基苯基、4-叔丁基苯基、4-氯苯基、4-溴苯基、3-硝基苯基、4-硝基苯基均属于取代苯基,在上述取代苯基中以苯环为母环,苯环中碳原子的编号是以与酰氧基相连的C为1位,其余碳原子根据现有技术中的编号原则进行编号。如3-甲基苯基中甲基位于酰氧基的间位。Preferably, R is selected from methyl, n-pentyl, naphthylene, benzylidene, 3-methylphenyl, 4-methylphenyl, 4-methoxyphenyl, 4-tert-butyl Any of phenyl, 4-chlorophenyl, 4-bromophenyl, 3-nitrophenyl, and 4-nitrophenyl. Among them, 3-methylphenyl, 4-methylphenyl, 4-methoxyphenyl, 4-tert-butylphenyl, 4-chlorophenyl, 4-bromophenyl, 3-nitrophenyl, 4-Nitrophenyl all belong to substituted phenyl, in the above-mentioned substituted phenyl, the benzene ring is used as the parent ring, and the numbering of the carbon atoms in the benzene ring is based on the C connected to the acyloxy group as the 1-position, and the remaining carbon atoms are based on the existing There are technical numbering principles for numbering. For example, in 3-methylphenyl, the methyl group is located in the meta position of the acyloxy group.

本发明在辛可宁的C9位中引入酯基形成了一系列9S-酰氧基辛可宁类衍生物,该类衍生物具有一定的杀虫活性,其中大部分衍生物的杀虫效果已超过商品化的植物源杀虫剂川楝素,具有较好的应用前景,为植物源农药的开发提供了新的方向。In the present invention, an ester group is introduced into the C9 position of cinchonine to form a series of 9S-acyloxycinchonine derivatives. Such derivatives have certain insecticidal activity, and the insecticidal effect of most of the derivatives has exceeded the commercialized ones. The botanical insecticide toosendanin has good application prospects and provides a new direction for the development of botanical pesticides.

一种上述9S-酰氧基辛可宁类衍生物的制备方法,包括以下步骤:在N,N'-二环己基碳二亚胺(DCC)和4-二甲胺基吡啶(DMAP)的作用下,辛可宁与羧酸在溶剂中进行酯化反应;所述羧酸的分子式为RCOOH,R选自烷基、苯亚烷基、萘亚烷基、苯基、取代苯基中的任一种;所述烷基中的碳原子个数为1~5;所述苯亚烷基、萘亚烷基中亚烷基的碳原子个数为1~4;所述取代苯基中的取代基为卤素、硝基、烷氧基、碳原子个数为1~4的烷基中的一种或多种,所述烷氧基中的碳原子个数为1~3。A preparation method of above-mentioned 9S-acyloxycinchonine derivatives, comprising the following steps: under the action of N,N'-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) , Cinchonine and carboxylic acid carry out esterification reaction in solvent; The molecular formula of described carboxylic acid is RCOOH, and R is selected from any one in alkyl, phenylalkylene, naphthylene, phenyl, substituted phenyl; The number of carbon atoms in the alkyl group is 1-5; the number of carbon atoms in the alkylene group in the phenylalkylene and naphthylene alkylene is 1-4; the substituent in the substituted phenyl group is One or more of halogens, nitro groups, alkoxy groups, and alkyl groups with 1 to 4 carbon atoms, and the number of carbon atoms in the alkoxy group is 1 to 3.

本发明以植物次生代谢物质辛可宁为先导化合物,采用Steglich酯化反应体系制备9S-酰氧基辛可宁类衍生物。本发明的制备方法反应条件温和,对辛可宁的构型影响较小,操作简单,适用于大规模生产。The invention uses the plant secondary metabolite cinchonine as the leading compound, and adopts the Steglich esterification reaction system to prepare 9S-acyloxycinchonine derivatives. The preparation method of the invention has mild reaction conditions, little influence on the configuration of cinchonine, simple operation, and is suitable for large-scale production.

在制备过程中所用溶剂能够溶解原料并不与原料反应即可。优选的,所用溶剂为二氯甲烷。The solvent used in the preparation process can dissolve the raw material and not react with the raw material. Preferably, the solvent used is dichloromethane.

通过优化各原料的用量来提高产物的产量,优选的,反应时,每摩尔的辛可宁对应使用(1~1.3)mol的羧酸。优选的,反应时,每摩尔的辛可宁对应使用(1~1.3)mol的N,N’-二环己基碳二亚胺,以及(0.1~0.3)mol的4-二甲胺基吡啶。The yield of the product is improved by optimizing the amount of each raw material. Preferably, during the reaction, (1-1.3) mol of carboxylic acid is used for each mole of cinchonine. Preferably, during the reaction, (1-1.3) mol of N,N'-dicyclohexylcarbodiimide and (0.1-0.3) mol of 4-dimethylaminopyridine are used for each mol of cinchonine.

本发明的9S-酰氧基辛可宁类衍生物的制备方法,还包括:反应结束后固液分离,得液相;然后对液相行稀释,然后洗涤、干燥;干燥后进行浓缩、分离。其中稀释所用溶剂为二氯甲烷。洗涤为依次采用盐酸、饱和碳酸氢钠溶液以及饱和食盐水洗涤。干燥为采用无水硫酸钠干燥。浓缩为减压浓缩。分离为采用柱层析分离。The preparation method of the 9S-acyloxycinchonine derivatives of the present invention further comprises: after the reaction is completed, solid-liquid separation is performed to obtain a liquid phase; then the liquid phase is diluted, washed and dried; and after drying, concentration and separation are performed. The solvent used for dilution is dichloromethane. The washing was successively washed with hydrochloric acid, saturated sodium bicarbonate solution and saturated brine. Drying is drying with anhydrous sodium sulfate. Concentrate under reduced pressure. The separation was carried out by column chromatography.

一种辛可宁或上述9S-酰氧基辛可宁类衍生物在防治虫害方面的应用。优选的,防治虫害为防治鳞翅目害虫引起的虫害。Application of cinchonine or the above-mentioned 9S-acyloxycinchonine derivatives in controlling insect pests. Preferably, the pest control is the pest control caused by Lepidopteran pests.

辛可宁以及本发明的9S-酰氧基辛可宁类衍生物均具有杀虫活性,因此可以用于虫害,尤其是鳞翅目害虫引起的虫害。Both cinchonine and the 9S-acyloxycinchonine derivatives of the present invention have insecticidal activity, so they can be used for insect pests, especially those caused by lepidopteran pests.

进一步优选的,所述鳞翅目虫害为粘虫虫害。Further preferably, the Lepidoptera pests are armyworm pests.

进一步优选的,辛可宁或本发明的9S-酰氧基辛可宁类衍生物通过诱导粘虫畸形生长实现粘虫虫害的防治。Further preferably, cinchonine or the 9S-acyloxycinchonine derivatives of the present invention can control armyworm pests by inducing abnormal growth of armyworms.

辛可宁以及本发明的9S-酰氧基辛可宁类衍生物在防治粘虫虫害时,通过使粘虫畸形从而导致死亡,降低了粘虫的存活率,从而实现了粘虫虫害的防治。When the cinchonine and the 9S-acyloxycinchonine derivatives of the present invention are used to prevent and control armyworm pests, they cause death by deforming armyworms and reduce the survival rate of armyworms, thereby realizing the control of armyworm pests.

本发明的植物源杀虫剂的技术方案为:The technical scheme of the botanical insecticide of the present invention is:

一种植物源杀虫剂,包括活性成分,所述活性成分中包括上述9S-酰氧基辛可宁类衍生物、辛可宁中的至少一种。A botanical insecticide, comprising active ingredients including at least one of the above-mentioned 9S-acyloxycinchonine derivatives and cinchonine.

辛可宁以及本发明的9S-酰氧基辛可宁类衍生物均具有较好的杀虫效果,因此以其作为活性成分的植物源杀虫剂具有较好的杀虫活性。Both cinchonine and the 9S-acyloxycinchonine derivatives of the present invention have good insecticidal effects, so the botanical insecticides using them as active ingredients have good insecticidal activities.

附图说明Description of drawings

图1为本发明的实施例1中化合物3a的氢谱图;Fig. 1 is the hydrogen spectrogram of compound 3a in the embodiment 1 of the present invention;

图2为本发明的实施例2中化合物3b的氢谱图;Fig. 2 is the hydrogen spectrogram of compound 3b in the embodiment 2 of the present invention;

图3为本发明的实施例3中化合物3c的氢谱图;Fig. 3 is the hydrogen spectrogram of compound 3c in the embodiment of the present invention 3;

图4为本发明的实施例27中杀虫活性测试时粘虫中异常幼虫的代表照片;4 is a representative photograph of abnormal larvae in armyworms during the insecticidal activity test in Example 27 of the present invention;

图5为本发明的实施例27中杀虫活性测试时粘虫中异常蛹的代表照片;5 is a representative photo of abnormal pupa in the armyworm during the insecticidal activity test in the embodiment of the present invention 27;

图6为本发明的实施例27中杀虫活性测试时粘虫中异常蛾的代表照片。6 is a representative photograph of abnormal moths among armyworms in the insecticidal activity test in Example 27 of the present invention.

具体实施方式Detailed ways

下面结合具体实施例以及附图对本发明作进一步说明。The present invention will be further described below with reference to specific embodiments and accompanying drawings.

一、9S-酰氧基辛可宁类衍生物的实施例1. Examples of 9S-acyloxycinchonine derivatives

各9S-酰氧基辛可宁类衍生物的实施例中的具体化合物及其物理性质如表1所示。Table 1 shows the specific compounds and their physical properties in the examples of each 9S-acyloxycinchonine derivative.

表1各实施例中的化合物及其物理性质Compounds and their physical properties in each example of Table 1

Figure BDA0002241523890000051
Figure BDA0002241523890000051

Figure BDA0002241523890000061
Figure BDA0002241523890000061

二、9S-酰氧基辛可宁类衍生物的制备方法的实施例Two, the embodiment of the preparation method of 9S-acyloxy cinchonine derivatives

以下实施例的制备过程中涉及的反应通式为:The general reaction formula involved in the preparation process of the following examples is:

在反应通式中,1为反应原料辛可宁;2a-2m为所用的一系列羧酸,分别为2a,……,2m;3a-3m为制得的化合物3a,……,3m;r.t.代表室温。In the general reaction formula, 1 is the reaction raw material cinchonine; 2a-2m are a series of carboxylic acids used, respectively 2a,..., 2m; 3a-3m are the prepared compounds 3a,..., 3m; r.t. represents room temperature .

实施例14Example 14

本实施例为实施例1中的化合物3a的制备方法,具体包括以下步骤:This embodiment is the preparation method of compound 3a in embodiment 1, and specifically comprises the following steps:

(1)分别称取0.5mmol的辛可宁(1)、0.6mmol的冰醋酸(2a)、0.6mmol的DCC和0.1mmol的DMAP置于50mL烧瓶中混合均匀,然后加入10mL的经氢化钙干燥后的二氯甲烷,混合均匀后在室温下反应,反应过程中采用TLC跟踪检测,原料反应完全后即反应结束;(1) Weigh 0.5 mmol of cinchonine (1), 0.6 mmol of glacial acetic acid (2a), 0.6 mmol of DCC and 0.1 mmol of DMAP, respectively, and place them in a 50 mL flask and mix well, then add 10 mL of calcium hydride-dried Dichloromethane, after mixing uniformly, react at room temperature, adopt TLC tracking detection during the reaction process, and the reaction ends after the reaction of the raw materials is complete;

(2)然后过滤除去脲,得滤液;将滤液采用40mL的二氯甲烷稀释的稀释液,然后将稀释液依次用0.1mol/L的盐酸(25mL)、饱和碳酸氢钠溶液(25mL)以及饱和食盐水(25mL)各洗涤依次,然后用无水硫酸钠干燥;干燥的稀释液进行减压蒸馏除去溶剂,得固体,然后对固体采用硅胶柱层析分离(洗脱液为体积比为1:1的乙酸乙酯和石油醚的混合液),得化合物3a(产率为21%)。(2) then remove urea by filtration to obtain a filtrate; the filtrate is diluted with 40 mL of dichloromethane, and then the dilution is sequentially used with 0.1 mol/L hydrochloric acid (25 mL), saturated sodium bicarbonate solution (25 mL) and saturated Each washing of brine (25mL) is successively followed by drying with anhydrous sodium sulfate; the dried diluent is carried out under reduced pressure distillation to remove the solvent to obtain a solid, and then the solid is separated by silica gel column chromatography (the eluent is that the volume ratio is 1: 1 of a mixture of ethyl acetate and petroleum ether) to obtain compound 3a (21% yield).

本实施例的制备过程中涉及的反应为:The reactions involved in the preparation process of the present embodiment are:

Figure BDA0002241523890000071
Figure BDA0002241523890000071

对得到的化合物3a进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,测试结果如图1所示,各峰的具体化学位移δ为:8.88(d,J=4.8Hz,1H),8.21(d,J=8.4Hz,1H),8.13(d,J=8.4Hz,1H),7.69-7.73(m,1H),7.57-7.61(m,1H),7.39(d,J=4.4Hz,1H),6.57(d,J=7.2Hz,1H),5.98-6.07(m,1H),5.07-5.13(m,2H),3.30(q,J=8.4Hz,1H),2.91(d,J=8.8Hz,2H),2.66-2.81(m,2H),2.29(q,J=8.4Hz,1H),2.12(s,3H),1.81-1.87(m,2H),1.50-1.56(m,3H)。The obtained compound 3a was subjected to a 400MHz hydrogen nuclear magnetic resonance spectrum test. The solvent used in the test was CDCl 3 , and TMS was the internal standard. The test results are shown in Figure 1. The specific chemical shift δ of each peak is: 8.88(d, J=4.8Hz, 1H), 8.21 (d, J=8.4Hz, 1H), 8.13 (d, J=8.4Hz, 1H), 7.69-7.73 (m, 1H), 7.57-7.61 (m, 1H), 7.39 (d, J=4.4Hz, 1H), 6.57 (d, J=7.2Hz, 1H), 5.98-6.07 (m, 1H), 5.07-5.13 (m, 2H), 3.30 (q, J=8.4Hz , 1H), 2.91(d, J=8.8Hz, 2H), 2.66-2.81(m, 2H), 2.29(q, J=8.4Hz, 1H), 2.12(s, 3H), 1.81-1.87(m, 2H), 1.50-1.56 (m, 3H).

化合物3a的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C21H25N2O2([M+H]+),337.1911;found,337.1913。The high-resolution chromatography (HRMS, ESI) test results of compound 3a are: Calcd for C 21 H 25 N 2 O 2 ([M+H] + ), 337.1911; found, 337.1913.

实施例15Example 15

本实施例为化合物3b的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为正己酸(2b),涉及的反应为:The present embodiment is the preparation method of compound 3b, and the specific reference is made to the preparation process of Example 14. The difference is only that: glacial acetic acid (2a) is replaced with n-hexanoic acid (2b), and the involved reactions are:

Figure BDA0002241523890000072
Figure BDA0002241523890000072

采用本实施例的制备方法制得的化合物3b的产率为39%。对制得的化合物3b进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,测试结果如图2所示,各峰的具体化学位移δ为:8.88(d,J=4.4Hz,1H),8.22(dd,J=8.8Hz,1.2Hz,1H),8.13(dd,J=8.4Hz,1.2Hz,1H),7.69-7.73(m,1H),7.57-7.61(m,1H),7.38(d,J=4.4Hz,1H),6.56(d,J=7.2Hz,1H),5.98-6.07(m,1H),5.07-5.13(m,2H),3.33(q,J=8.4Hz,1H),2.85-2.95(m,2H),2.65-2.80(m,2H),2.32-2.41(m,2H),2.22-2.29(m,1H),1.80-1.85(m,2H),1.51-1.58(m,3H),1.19-1.29(m,4H),0.89-0.98(m,2H),0.86(t,J=7.2Hz,3H)。The yield of compound 3b prepared by the preparation method of this example was 39%. The obtained compound 3b was subjected to a 400MHz hydrogen nuclear magnetic resonance spectrum test. The solvent used in the test was CDCl 3 , and TMS was the internal standard. The test results are shown in Figure 2. The specific chemical shift δ of each peak is: 8.88 (d , J=4.4Hz, 1H), 8.22 (dd, J=8.8Hz, 1.2Hz, 1H), 8.13 (dd, J=8.4Hz, 1.2Hz, 1H), 7.69-7.73 (m, 1H), 7.57- 7.61 (m, 1H), 7.38 (d, J=4.4Hz, 1H), 6.56 (d, J=7.2Hz, 1H), 5.98-6.07 (m, 1H), 5.07-5.13 (m, 2H), 3.33 (q, J=8.4Hz, 1H), 2.85-2.95(m, 2H), 2.65-2.80(m, 2H), 2.32-2.41(m, 2H), 2.22-2.29(m, 1H), 1.80-1.85 (m, 2H), 1.51-1.58 (m, 3H), 1.19-1.29 (m, 4H), 0.89-0.98 (m, 2H), 0.86 (t, J=7.2Hz, 3H).

化合物3b的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C25H33N2O2([M+H]+),393.2537;found,393.2539。The high-resolution chromatography (HRMS, ESI) test results of compound 3b are: Calcd for C 25 H 33 N 2 O 2 ([M+H] + ), 393.2537; found, 393.2539.

实施例16Example 16

本实施例为化合物3c的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为苯甲酸(2c),涉及的反应为:The present embodiment is the preparation method of compound 3c, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced by benzoic acid (2c), and the reactions involved are:

Figure BDA0002241523890000081
Figure BDA0002241523890000081

采用本实施例的制备方法制得的化合物3c的产率为54%。对制得的化合物3c进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,测试结果如图3所示,各峰的具体化学位移δ为:8.87(d,J=4.4Hz,1H),8.32(dd,J=8.4Hz,1.2Hz,1H),8.08-8.14(m,3H),7.70-7.74(m,1H),7.57-7.65(m,2H),7.44-7.48(m,3H),6.80(d,J=7.2Hz,1H),5.98-6.07(m,1H),5.06-5.13(m,2H),3.48(q,J=8.4Hz,1H),2.90-3.03(m,2H),2.68-2.85(m,2H),2.25-2.32(m,1H),1.94-2.01(m,1H),1.85-1.87(m,1H),1.56-1.69(m,3H)。The yield of compound 3c prepared by the preparation method of this example was 54%. The obtained compound 3c was subjected to a 400MHz hydrogen nuclear magnetic resonance spectrum test. The solvent used in the test was CDCl 3 , and TMS was the internal standard. The test results are shown in Figure 3. The specific chemical shift δ of each peak is: 8.87(d , J=4.4Hz, 1H), 8.32 (dd, J=8.4Hz, 1.2Hz, 1H), 8.08-8.14 (m, 3H), 7.70-7.74 (m, 1H), 7.57-7.65 (m, 2H) , 7.44-7.48(m, 3H), 6.80(d, J=7.2Hz, 1H), 5.98-6.07(m, 1H), 5.06-5.13(m, 2H), 3.48(q, J=8.4Hz, 1H) ), 2.90-3.03(m, 2H), 2.68-2.85(m, 2H), 2.25-2.32(m, 1H), 1.94-2.01(m, 1H), 1.85-1.87(m, 1H), 1.56-1.69 (m, 3H).

化合物3c的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C26H27N2O2([M+H]+),399.2067;found,399.2071。The high-resolution chromatography (HRMS, ESI) test results of compound 3c are: Calcd for C 26 H 27 N 2 O 2 ([M+H] + ), 399.2067; found, 399.2071.

实施例17Example 17

本实施例为化合物3d的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为间甲基苯甲酸(2d),涉及的反应为:The present embodiment is the preparation method of compound 3d, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with m-toluic acid (2d), and the reactions involved are:

Figure BDA0002241523890000082
Figure BDA0002241523890000082

采用本实施例的制备方法制得的化合物3d的产率为46%。对制得的化合物3d进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.87(d,J=4.8Hz,1H),8.31(dd,J=8.4Hz,1.2Hz,1H),8.14(dd,J=8.4Hz,1.2Hz,1H),7.88-7.90(m,2H),7.70-7.74(m,1H),7.61-7.65(m,1H),7.47(d,J=4.4Hz,1H),7.32-7.41(m,2H),6.81(d,J=6.8Hz,1H),6.00-6.09(m,1H),5.06-5.14(m,2H),3.46(q,J=8.4Hz,1H),2.90-3.04(m,2H),2.80-2.87(m,1H),2.69-2.77(m,1H),2.41(s,3H),2.25-2.32(m,1H),1.96-2.03(m,1H),1.84-1.88(m,1H),1.54-1.66(m,3H)。The yield of compound 3d prepared by the preparation method of this example was 46%. The prepared compound 3d was subjected to a 400MHz hydrogen nuclear magnetic resonance spectrum test, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.87 (d, J=4.8Hz, 1H), 8.31 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.14 (dd, J=8.4Hz, 1.2Hz, 1H), 7.88-7.90 (m, 2H), 7.70-7.74 (m, 1H), 7.61-7.65 ( m, 1H), 7.47 (d, J=4.4Hz, 1H), 7.32-7.41 (m, 2H), 6.81 (d, J=6.8Hz, 1H), 6.00-6.09 (m, 1H), 5.06-5.14 (m, 2H), 3.46 (q, J=8.4Hz, 1H), 2.90-3.04 (m, 2H), 2.80-2.87 (m, 1H), 2.69-2.77 (m, 1H), 2.41 (s, 3H) ), 2.25-2.32 (m, 1H), 1.96-2.03 (m, 1H), 1.84-1.88 (m, 1H), 1.54-1.66 (m, 3H).

化合物3d的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C27H29N2O2([M+H]+),413.2224;found,413.2228。The high-resolution chromatography (HRMS, ESI) test results of compound 3d are: Calcd for C 27 H 29 N 2 O 2 ([M+H] + ), 413.2224; found, 413.2228.

实施例18Example 18

本实施例为化合物3e的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对甲基苯甲酸(2e),涉及的反应为:The present embodiment is the preparation method of compound 3e, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-toluic acid (2e), and the reactions involved are:

Figure BDA0002241523890000091
Figure BDA0002241523890000091

采用本实施例的制备方法制得的化合物3e的产率为39%。对制得的化合物3e进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.86(d,J=4.8Hz,1H),8.31(dd,J=8.4Hz,1.2Hz,1H),8.13(dd,J=8.4Hz,1.2Hz,1H),7.96-7.99(m,2H),7.69-7.73(m,1H),7.60-7.64(m,1H),7.46(d,J=4.4Hz,1H),7.24-7.27(m,2H),6.78(d,J=7.2Hz,1H),5.99-6.07(m,1H),5.06-5.13(m,2H),3.46(q,J=8.4Hz,1H),2.89-3.03(m,2H),2.68-2.85(m,2H),2.41(s,3H,),2.24-2.31(m,1H),1.94-2.00(m,1H),1.85(s,1H),1.54-1.67(m,3H)。The yield of compound 3e prepared by the preparation method of this example was 39%. The prepared compound 3e was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.86 (d, J=4.8Hz, 1H), 8.31 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.13 (dd, J=8.4Hz, 1.2Hz, 1H), 7.96-7.99 (m, 2H), 7.69-7.73 (m, 1H), 7.60-7.64 ( m, 1H), 7.46 (d, J=4.4Hz, 1H), 7.24-7.27 (m, 2H), 6.78 (d, J=7.2Hz, 1H), 5.99-6.07 (m, 1H), 5.06-5.13 (m, 2H), 3.46 (q, J=8.4Hz, 1H), 2.89-3.03 (m, 2H), 2.68-2.85 (m, 2H), 2.41 (s, 3H, ), 2.24-2.31 (m, 1H), 1.94-2.00 (m, 1H), 1.85 (s, 1H), 1.54-1.67 (m, 3H).

化合物3e的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C27H29N2O2([M+H]+),413.2224;found,413.2226。The high-resolution chromatography (HRMS, ESI) test results of compound 3e are: Calcd for C 27 H 29 N 2 O 2 ([M+H] + ), 413.2224; found, 413.2226.

实施例19Example 19

本实施例为化合物3f的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对甲氧基苯甲酸(2f),涉及的反应为:The present embodiment is the preparation method of compound 3f, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-methoxybenzoic acid (2f), and the reactions involved are:

Figure BDA0002241523890000092
Figure BDA0002241523890000092

采用本实施例的制备方法制得的化合物3f的产率为53%。对制得的化合物3f进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.87(d,J=4.4Hz,1H),8.34(dd,J=8.4Hz,1.2Hz,1H),8.14(dd,J=8.4Hz,1.2Hz,1H),8.03-8.07(m,2H),7.70-7.74(m,1H),7.60-7.64(m,1H),7.46(d,J=4.4Hz,1H),6.92-6.95(m,2H),6.83(d,J=6.8Hz,1H),5.99-6.07(m,1H),5.06-5.15(m,2H),3.86(s,3H),3.47(q,J=8.4Hz,1H),2.94-3.06(m,2H),2.83-2.90(m,1H),2.71-2.79(m,1H),2.27-2.34(m,1H),1.98-2.02(m,1H),1.86-1.89(m,1H),1.56-1.65(m,3H)。The yield of compound 3f prepared by the preparation method of this example was 53%. The prepared compound 3f was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.87 (d, J=4.4Hz, 1H), 8.34 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.14 (dd, J=8.4Hz, 1.2Hz, 1H), 8.03-8.07 (m, 2H), 7.70-7.74 (m, 1H), 7.60-7.64 ( m, 1H), 7.46 (d, J=4.4Hz, 1H), 6.92-6.95 (m, 2H), 6.83 (d, J=6.8Hz, 1H), 5.99-6.07 (m, 1H), 5.06-5.15 (m, 2H), 3.86 (s, 3H), 3.47 (q, J=8.4Hz, 1H), 2.94-3.06 (m, 2H), 2.83-2.90 (m, 1H), 2.71-2.79 (m, 1H) ), 2.27-2.34 (m, 1H), 1.98-2.02 (m, 1H), 1.86-1.89 (m, 1H), 1.56-1.65 (m, 3H).

化合物3e的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C27H29N2O3([M+H]+),429.2173;found,429.2178。The high-resolution chromatography (HRMS, ESI) test results of compound 3e are: Calcd for C 27 H 29 N 2 O 3 ([M+H] + ), 429.2173; found, 429.2178.

实施例20Example 20

本实施例为化合物3g的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对叔丁基苯甲酸(2g),涉及的反应为:The present embodiment is the preparation method of compound 3g, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-tert-butylbenzoic acid (2g), and the reactions involved are:

Figure BDA0002241523890000101
Figure BDA0002241523890000101

采用本实施例的制备方法制得的化合物3g的产率为50%。对制得的化合物3g进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.86(d,J=4.4Hz,1H),8.32(dd,J=8.4Hz,1.2Hz,1H),8.13(dd,J=8.4Hz,1.2Hz,1H),8.01-8.04(m,2H),7.69-7.74(m,1H),7.60-7.64(m,1H),7.45-7.49(m,3H),6.79(d,J=7.2Hz,1H),5.99-6.08(m,1H),5.06-5.14(m,2H),3.47(q,J=8.4Hz,1H),2.91-3.04(m,2H),2.69-2.85(m,2H),2.32(q,J=8.4Hz,1H),1.94-2.00(m,1H),1.86(s,1H),1.56-1.66(m,3H),1.34(s,9H)。The yield of compound 3g prepared by the preparation method of this example was 50%. The prepared compound 3g was subjected to 400MHz hydrogen nuclear magnetic resonance spectrum test, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.86 (d, J=4.4Hz, 1H), 8.32 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.13 (dd, J=8.4Hz, 1.2Hz, 1H), 8.01-8.04 (m, 2H), 7.69-7.74 (m, 1H), 7.60-7.64 ( m, 1H), 7.45-7.49 (m, 3H), 6.79 (d, J=7.2Hz, 1H), 5.99-6.08 (m, 1H), 5.06-5.14 (m, 2H), 3.47 (q, J= 8.4Hz, 1H), 2.91-3.04(m, 2H), 2.69-2.85(m, 2H), 2.32(q, J=8.4Hz, 1H), 1.94-2.00(m, 1H), 1.86(s, 1H) ), 1.56-1.66 (m, 3H), 1.34 (s, 9H).

化合物3g的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C30H35N2O2([M+H]+),455.2693;found,455.2695。The high-resolution chromatography (HRMS, ESI) test results of compound 3g are: Calcd for C 30 H 35 N 2 O 2 ([M+H] + ), 455.2693; found, 455.2695.

实施例21Example 21

本实施例为化合物3h的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对氯苯甲酸(2h),涉及的反应为:The present embodiment is the preparation method of compound 3h, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-chlorobenzoic acid (2h), and the involved reactions are:

Figure BDA0002241523890000102
Figure BDA0002241523890000102

采用本实施例的制备方法制得的化合物3h的产率为22%。对制得的化合物3h进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.88(d,J=4.4Hz,1H),8.29(dd,J=8.4Hz,1.2Hz,1H),8.14(dd,J=8.4Hz,1.2Hz,1H),8.03(t,J=2.4Hz,1H),8.01(t,J=2.4Hz,1H),7.70-7.75(m,1H),7.60-7.65(m,1H),7.42-7.45(m,3H),6.78(d,J=7.6Hz,1H),5.97-6.05(m,1H),5.06-5.14(m,2H),3.47(q,J=8.4Hz,1H),2.89-3.00(m,2H),2.68-2.79(m,2H),2.25-2.32(m,1H),1.85-1.96(m,2H),1.55-1.68(m,3H)。The yield of compound 3h prepared by the preparation method of this example was 22%. The prepared compound 3h was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.88 (d, J=4.4Hz, 1H), 8.29 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.14 (dd, J=8.4Hz, 1.2Hz, 1H), 8.03 (t, J=2.4Hz, 1H), 8.01 (t, J=2.4Hz, 1H) ), 7.70-7.75(m, 1H), 7.60-7.65(m, 1H), 7.42-7.45(m, 3H), 6.78(d, J=7.6Hz, 1H), 5.97-6.05(m, 1H), 5.06-5.14(m, 2H), 3.47(q, J=8.4Hz, 1H), 2.89-3.00(m, 2H), 2.68-2.79(m, 2H), 2.25-2.32(m, 1H), 1.85- 1.96 (m, 2H), 1.55-1.68 (m, 3H).

化合物3h的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C26H26ClN2O2([M+H]+),433.1677;found,433.1678。The results of high resolution chromatography (HRMS, ESI) of compound 3h are: Calcd for C 26 H 26 ClN 2 O 2 ([M+H] + ), 433.1677; found, 433.1678.

实施例22Example 22

本实施例为化合物3i的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对溴苯甲酸(2i),涉及的反应为:The present embodiment is the preparation method of compound 3i, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-bromobenzoic acid (2i), and the reaction involved is:

Figure BDA0002241523890000111
Figure BDA0002241523890000111

采用本实施例的制备方法制得的化合物3i的产率为36%。对制得的化合物3h进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.88(d,J=4.8Hz,1H),8.29(dd,J=8.8Hz,1.2Hz,1H),8.14(dd,J=8.4Hz,1.6Hz,1H),7.92-7.95(m,2H),7.70-7.74(m,1H),7.58-7.64(m,3H),7.44(d,J=4.4Hz,1H),6.77(d,J=7.6Hz,1H),5.96-6.05(m,1H),5.06-5.14(m,2H),3.47(q,J=8.4Hz,1H),2.89-2.99(m,2H),2.68-2.84(m,2H),2.25-2.32(m,1H),1.85-1.96(m,2H),1.54-1.68(m,3H)。The yield of compound 3i prepared by the preparation method of this example was 36%. The prepared compound 3h was subjected to 400MHz hydrogen nuclear magnetic resonance spectrum test, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.88 (d, J=4.8Hz, 1H), 8.29 ( dd, J=8.8Hz, 1.2Hz, 1H), 8.14 (dd, J=8.4Hz, 1.6Hz, 1H), 7.92-7.95 (m, 2H), 7.70-7.74 (m, 1H), 7.58-7.64 ( m, 3H), 7.44 (d, J=4.4Hz, 1H), 6.77 (d, J=7.6Hz, 1H), 5.96-6.05 (m, 1H), 5.06-5.14 (m, 2H), 3.47 (q , J=8.4Hz, 1H), 2.89-2.99(m, 2H), 2.68-2.84(m, 2H), 2.25-2.32(m, 1H), 1.85-1.96(m, 2H), 1.54-1.68(m , 3H).

化合物3i的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C26H26BrN2O2([M+H]+),477.1172;found,477.1177。The results of high resolution chromatography (HRMS, ESI) of compound 3i are: Calcd for C 26 H 26 BrN 2 O 2 ([M+H] + ), 477.1172; found, 477.1177.

实施例23Example 23

本实施例为化合物3j的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为间硝基苯甲酸(2j),涉及的反应为:The present embodiment is the preparation method of compound 3j, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with m-nitrobenzoic acid (2j), and the reactions involved are:

Figure BDA0002241523890000112
Figure BDA0002241523890000112

采用本实施例的制备方法制得的化合物3j的产率为48%。对制得的化合物3j进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.92(t,J=2.0Hz,1H),8.90(d,J=4.4Hz,1H),8.43-8.46(m,1H),8.36-8.39(m,1H),8.31(dd,J=8.4Hz,1.2Hz,1H),8.15(dd,J=8.4Hz,1.6Hz,1H),7.72-7.76(m,1H),7.63-7.69(m,2H),7.48(d,J=4.8Hz,1H),6.83(d,J=7.6Hz,1H),6.00-6.09(m,1H),5.07-5.16(m,2H),3.54(q,J=8.4Hz,1H),2.96(dd,J=8.8Hz,1.2Hz,2H),2.80-2.86(m,1H),2.69-2.76(m,1H),2.26-2.34(m,1H),1.88-1.98(m,2H),1.68-1.73(m,1H),1.56-1.64(m,2H)。The yield of compound 3j prepared by the preparation method of this example was 48%. The prepared compound 3j was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.92 (t, J=2.0Hz, 1H), 8.90 ( d, J=4.4Hz, 1H), 8.43-8.46 (m, 1H), 8.36-8.39 (m, 1H), 8.31 (dd, J=8.4Hz, 1.2Hz, 1H), 8.15 (dd, J=8.4 Hz, 1.6Hz, 1H), 7.72-7.76 (m, 1H), 7.63-7.69 (m, 2H), 7.48 (d, J=4.8Hz, 1H), 6.83 (d, J=7.6Hz, 1H), 6.00-6.09 (m, 1H), 5.07-5.16 (m, 2H), 3.54 (q, J=8.4Hz, 1H), 2.96 (dd, J=8.8Hz, 1.2Hz, 2H), 2.80-2.86 (m , 1H), 2.69-2.76 (m, 1H), 2.26-2.34 (m, 1H), 1.88-1.98 (m, 2H), 1.68-1.73 (m, 1H), 1.56-1.64 (m, 2H).

化合物3j的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C26H26N3O4([M+H]+),444.1918;found,444.1919。The high-resolution chromatography (HRMS, ESI) test results of compound 3j are: Calcd for C 26 H 26 N 3 O 4 ([M+H] + ), 444.1918; found, 444.1919.

实施例24Example 24

本实施例为化合物3k的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为对硝基苯甲酸(2k),涉及的反应为:The present embodiment is the preparation method of compound 3k, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with p-nitrobenzoic acid (2k), and the reactions involved are:

采用本实施例的制备方法制得的化合物3k的产率为32%。对制得的化合物3k进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.90(d,J=4.8Hz,1H),8.23-8.32(m,5H),8.15(dd,J=8.4Hz,1.2Hz,1H),7.72-7.76(m,1H),7.62-7.66(m,1H),7.46(d,J=4.4Hz,1H),6.81(d,J=7.6Hz,1H),5.96-6.05(m,1H),5.07-5.16(m,2H),3.52(q,J=8.4Hz,1H),2.95(d,J=8.8Hz,2H),2.68-2.85(m,2H),2.26-2.34(m,1H),1.87-1.93(m,2H),1.65-1.72(m,1H),1.56-1.62(m,2H)。The yield of compound 3k prepared by the preparation method of this example was 32%. The prepared compound 3k was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.90 (d, J=4.8Hz, 1H), 8.23- 8.32(m, 5H), 8.15(dd, J=8.4Hz, 1.2Hz, 1H), 7.72-7.76(m, 1H), 7.62-7.66(m, 1H), 7.46(d, J=4.4Hz, 1H) ), 6.81(d, J=7.6Hz, 1H), 5.96-6.05(m, 1H), 5.07-5.16(m, 2H), 3.52(q, J=8.4Hz, 1H), 2.95(d, J= 8.8Hz, 2H), 2.68-2.85(m, 2H), 2.26-2.34(m, 1H), 1.87-1.93(m, 2H), 1.65-1.72(m, 1H), 1.56-1.62(m, 2H) .

化合物3k的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C26H26N3O4([M+H]+),444.1918;found,444.1923。The high-resolution chromatography (HRMS, ESI) test results of compound 3k are: Calcd for C 26 H 26 N 3 O 4 ([M+H] + ), 444.1918; found, 444.1923.

实施例25Example 25

本实施例为化合物3l的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为萘乙酸(2l),涉及的反应为:The present embodiment is the preparation method of compound 31, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with naphthalene acetic acid (21), and the reactions involved are:

Figure BDA0002241523890000131
Figure BDA0002241523890000131

采用本实施例的制备方法制得的化合物3l的产率为32%。对制得的化合物3l进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.59(d,J=4.8Hz,1H),8.07(dd,J=8.4Hz,1.2Hz,1H),8.02(dd,J=8.4Hz,1.2Hz,1H),7.89(dd,J=8.4Hz,1.2Hz,1H),7.81-7.83(m,2H),7.63-7.67(m,1H),7.36-7.49(m,5H),6.88(d,J=4.4Hz,1H),6.50(d,J=7.2Hz,1H),5.82-5.91(m,1H),5.02-5.10(m,2H),4.12(s,2H),3.16(q,J=8.4Hz,1H),2.80-2.83(m,2H),2.58-2.68(m,2H),2.15-2.66(m,1H),1.66-1.70(m,1H),1.54-1.61(m,1H),1.41-1.46(m,2H),1.18-1.25(m,1H)。The yield of compound 31 prepared by the preparation method of this example was 32%. The prepared compound 31 was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.59 (d, J=4.8Hz, 1H), 8.07 ( dd, J=8.4Hz, 1.2Hz, 1H), 8.02 (dd, J=8.4Hz, 1.2Hz, 1H), 7.89 (dd, J=8.4Hz, 1.2Hz, 1H), 7.81-7.83 (m, 2H) ), 7.63-7.67(m, 1H), 7.36-7.49(m, 5H), 6.88(d, J=4.4Hz, 1H), 6.50(d, J=7.2Hz, 1H), 5.82-5.91(m, 1H), 5.02-5.10(m, 2H), 4.12(s, 2H), 3.16(q, J=8.4Hz, 1H), 2.80-2.83(m, 2H), 2.58-2.68(m, 2H), 2.15 -2.66 (m, 1H), 1.66-1.70 (m, 1H), 1.54-1.61 (m, 1H), 1.41-1.46 (m, 2H), 1.18-1.25 (m, 1H).

化合物3l的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C31H31N2O2([M+H]+),463.2380;found,463.2387。The high-resolution chromatography (HRMS, ESI) test results of compound 31 are: Calcd for C 31 H 31 N 2 O 2 ([M+H] + ), 463.2380; found, 463.2387.

实施例26Example 26

本实施例为化合物3m的制备方法,具体参照实施例14的制备过程,区别仅在于:将冰醋酸(2a)替换为苯乙酸(2m),涉及的反应为:The present embodiment is the preparation method of compound 3m, with specific reference to the preparation process of Example 14, the difference is only that: glacial acetic acid (2a) is replaced with phenylacetic acid (2m), and the reactions involved are:

Figure BDA0002241523890000132
Figure BDA0002241523890000132

采用本实施例的制备方法制得的化合物3m的产率为38%。对制得的化合物3m进行400MHz的核磁共振氢谱测试,测试时采用的溶剂为CDCl3,TMS为内标物,具体化学位移δ为:8.81(d,J=4.4Hz,1H),8.11-8.17(m,2H),7.69-7.73(m,1H),7.55-7.59(m,1H),7.23-7.25(m,2H),7.22(d,J=4.4Hz,1H),6.97-7.01(m,1H),6.83-6.86(m,2H),6.66(d,J=7.6Hz,1H),5.98-6.07(m,1H),5.07-5.12(m,2H),4.68(d,J=2.4Hz,2H),3.34(q,J=8.4Hz,1H),2.89(d,J=8.4Hz,2H),2.64-2.79(m,2H),2.22-2.28(m,1H),1.77-1.80(m,2H),1.47-1.55(m,3H)。The yield of compound 3m prepared by the preparation method of this example was 38%. The prepared compound 3m was tested by 400MHz hydrogen nuclear magnetic resonance spectrum, the solvent used in the test was CDCl 3 , TMS was the internal standard, and the specific chemical shift δ was: 8.81 (d, J=4.4Hz, 1H), 8.11- 8.17(m, 2H), 7.69-7.73(m, 1H), 7.55-7.59(m, 1H), 7.23-7.25(m, 2H), 7.22(d, J=4.4Hz, 1H), 6.97-7.01( m, 1H), 6.83-6.86 (m, 2H), 6.66 (d, J=7.6Hz, 1H), 5.98-6.07 (m, 1H), 5.07-5.12 (m, 2H), 4.68 (d, J= 2.4Hz, 2H), 3.34 (q, J=8.4Hz, 1H), 2.89 (d, J=8.4Hz, 2H), 2.64-2.79 (m, 2H), 2.22-2.28 (m, 1H), 1.77- 1.80 (m, 2H), 1.47-1.55 (m, 3H).

化合物3m的高分辨率色谱(HRMS,ESI)测试结果为:Calcd for C27H29N2O2([M+H]+),413.2224;found,413.2222。The results of high resolution chromatography (HRMS, ESI) of compound 3m are: Calcd for C 27 H 29 N 2 O 2 ([M+H] + ), 413.2224; found, 413.2222.

三、植物源杀虫剂的实施例3. Examples of botanical insecticides

实施例27Example 27

本实施例的植物源杀虫剂为由实施例1中的化合物3a与丙酮配制成的浓度为1mg/mL的混合溶液。The botanical insecticide in this example is a mixed solution with a concentration of 1 mg/mL prepared from Compound 3a in Example 1 and acetone.

在植物源杀虫剂其他实施例中,还可以将现有的植物源杀虫剂中的活性成分如川楝素替换为辛可宁或本发明的9S-酰氧基辛可宁类衍生物中的3j或3m。也可以将辛可宁和/或本发明的9S-酰氧基辛可宁类衍生物作为活性成分,与现有的其他种类的活性成分进行复配,并根据现有的加工方法加工成复配型杀虫剂。In other embodiments of the botanical insecticide, the active ingredient in the existing botanical insecticide, such as toosendanin, can also be replaced by cinchonine or 3j or 3j in the 9S-acyloxycinchonine derivatives of the present invention. 3m. Cinchonine and/or 9S-acyloxycinchonine derivatives of the present invention can also be used as active ingredients, compounded with other existing active ingredients, and processed into compounded insecticides according to existing processing methods. agent.

四、试验例4. Test case

对实施例1~13中的化合物3a~3m及辛可宁分别采用小叶碟添加法进行杀鳞翅目害虫粘虫活性测试。试虫为三龄前期粘虫,以商品化植物源杀虫剂川楝素(Toosendanin)作为阳性对照组。具体试验过程如下:The compounds 3a to 3m and cinchonin in Examples 1 to 13 were respectively tested for their activity against lepidopteran insect armyworm by adding a small leaf disc. The test insects were the first third instar armyworm, and the commercial plant-derived insecticide Toosendanin was used as the positive control group. The specific test process is as follows:

1)将化合物3a~3m、辛可宁及川楝素分别配制成浓度为1mg/mL的丙酮溶液,得3a~3m的药液、辛可宁药液和川楝素药液;将新鲜的玉米叶片剪成1cm×1cm的小叶碟,然后在3a~3m的药液、辛可宁药液、川楝素药液(阳性对照)及纯丙酮药液(空白对照)中浸3s,自然晾干后备用。1) Compounds 3a~3m, Cinchonin and Toosendanin are respectively prepared into acetone solutions with a concentration of 1 mg/mL to obtain the medicinal liquid of 3a~3m, the medicinal liquid of Cinchoning and the medicinal solution of Toosendanin; the fresh corn leaves are cut into 1cm ×1cm small-leaf plate, then immersed in 3a-3m liquid medicine, Xinkening liquid, toosendanin liquid (positive control) and pure acetone liquid (blank control) for 3s, and dried naturally for later use.

2)将晾干后的小叶碟分别饲养试虫,待试虫吃完小叶碟后,及时添加晾干后的小叶碟,饲养48h后换喂正常的叶片(即未浸泡药液的小叶碟)直至羽化;每种药液设三个重复,每个重复挑选10头健壮、大小均一的三龄前期粘虫,饲养于直径为9cm的培养皿中,培养皿底部铺一层滤纸以便保湿。饲养条件为:温度25±2℃,相对湿度为65~80%,光照时间12h,黑暗时间12h,光照和黑暗依次间隔进行。2) Feed the test worms on the dried leaflets respectively. After the test worms have eaten the leaflets, add the dried leaflets in time, and feed the normal leaves (ie, the leaflets without the liquid medicine) after feeding for 48 hours. Until eclosion; three replicates were set for each medicinal solution, and 10 robust, uniform-sized pre-third-instar armyworms were selected for each replicate and reared in a petri dish with a diameter of 9 cm. The rearing conditions were as follows: temperature 25±2°C, relative humidity 65-80%, light time 12h, dark time 12h, light and dark were carried out at intervals in turn.

3)在饲养期间,记录试虫的不同时期的死亡率(%),根据下列公式计算:校正死亡率(%)=(处理组死亡率-对照组死亡率)*100/(1-对照组死亡率),其中对照组死亡率即为空白对照组的死亡率。计算结果如表2所示。3) During the feeding period, record the mortality rate (%) of the test worms in different periods, and calculate according to the following formula: Corrected mortality rate (%)=(death rate of treatment group-death rate of control group)*100/(1-control group death rate), where the death rate of the control group was the death rate of the blank control group. The calculation results are shown in Table 2.

表2杀虫活性结果Table 2 Insecticidal activity results

Figure BDA0002241523890000141
Figure BDA0002241523890000141

Figure BDA0002241523890000151
Figure BDA0002241523890000151

试验结果表明:辛可宁对于粘虫的杀虫效果显著,杀虫效果已超过商品化的植物源杀虫剂川楝素。本发明的9S-酰氧基辛可宁类衍生物(化合物3a~3m)中的3c、3d、3g、3h和3j-m对粘虫的杀虫效果同样超过了川楝素,特别是化合物3j和3m;其化合物3a的杀虫效果与川楝素相同,化合物3b、3e、3f在短时间内(10天)的杀虫效果仍优于川楝素;化合物3i在短时间(10天以及20天)的杀虫效果与川楝素相同。The test results showed that the insecticidal effect of Cinchonin on armyworms was remarkable, and the insecticidal effect had surpassed the commercial plant-derived insecticide toosendanin. The insecticidal effects of 3c, 3d, 3g, 3h and 3j-m in the 9S-acyloxycinchonine derivatives (compounds 3a to 3m) of the present invention on armyworms are also more than those of toosendanin, especially compounds 3j and 3j-m. 3m; the insecticidal effect of compound 3a is the same as that of toosendanin, and the insecticidal effect of compounds 3b, 3e, and 3f is still better than that of toosendanin in a short time (10 days); day), the insecticidal effect is the same as that of senimin.

在试验期间,挑选出幼虫期、蛹期和蛾期的异常虫进行拍照,如图4~图6所示(图中CK为空白对照组中正常试虫)。由图4~图6可知,辛可宁以及本发明的辛可宁类衍生物能够使粘虫畸形生长从而死亡。During the test, the abnormal worms in the larval stage, the pupal stage and the moth stage were selected and photographed, as shown in Figures 4 to 6 (CK in the figure is the normal test worm in the blank control group). As can be seen from FIGS. 4 to 6 , cinchonine and the cinchonine derivatives of the present invention can cause abnormal growth of armyworms and death.

杀虫活性测试结果表明,辛可宁及本发明的9S-酰氧基辛可宁类衍生物具有较好的杀虫活性,尤其是针对鳞翅目害虫粘虫,因此可以用于防治虫害。The test results of insecticidal activity show that cinchonine and the 9S-acyloxycinchonine derivatives of the present invention have good insecticidal activity, especially against lepidopteran insect armyworm, so they can be used to control insect pests.

Claims (10)

1.一种9S-酰氧基辛可宁类衍生物,其特征在于,该9S-酰氧基辛可宁类衍生物的结构式为:1. a 9S-acyloxy cinchonine derivative, is characterized in that, the structural formula of this 9S-acyloxycinchonine derivative is: 其中,R选自烷基、苯亚烷基、萘亚烷基、苯基、取代苯基中的任一种;所述烷基中的碳原子个数为1~5;所述苯亚烷基、萘亚烷基中亚烷基的碳原子个数为1~4;所述取代苯基中的取代基为卤素、硝基、烷氧基、碳原子个数为1~4的烷基中的一种或多种,所述烷氧基中的碳原子个数为1~3。Wherein, R is selected from any one of alkyl, phenylalkylene, naphthylene, phenyl, and substituted phenyl; the number of carbon atoms in the alkyl is 1 to 5; the phenylene The number of carbon atoms in the alkylene group is 1 to 4; the substituents in the substituted phenyl group are halogen, nitro, alkoxy, and alkyl with 1 to 4 carbon atoms. One or more of the alkoxy groups, the number of carbon atoms in the alkoxy group is 1-3. 2.根据权利要求1所述的9S-酰氧基辛可宁类衍生物,其特征在于,R选自甲基、戊基、苯亚甲基、萘亚甲基、苯基、取代苯基中的任一种;所述取代苯基中的取代基为氯、溴、硝基、甲氧基、甲基、丁基中的一种或多种。2. 9S-acyloxycinchonine derivatives according to claim 1, is characterized in that, R is selected from among methyl, amyl, benzylidene, naphthylmethylene, phenyl, substituted phenyl Any; the substituent in the substituted phenyl group is one or more of chlorine, bromine, nitro, methoxy, methyl, and butyl. 3.根据权利要求1或2所述的9S-酰氧基辛可宁类衍生物,其特征在于,R选自甲基、正戊基、3-甲基苯基、4-甲基苯基、4-甲氧基苯基、4-叔丁基苯基、4-氯苯基、4-溴苯基、3-硝基苯基、4-硝基苯基、萘亚甲基、苯亚甲基中的任意一种。3. 9S-acyloxy cinchonine derivatives according to claim 1 or 2, wherein R is selected from methyl, n-pentyl, 3-methylphenyl, 4-methylphenyl, 4 -Methoxyphenyl, 4-tert-butylphenyl, 4-chlorophenyl, 4-bromophenyl, 3-nitrophenyl, 4-nitrophenyl, naphthylmethylene, benzylidene any of the . 4.根据权利要求1~3任一项所述的9S-酰氧基辛可宁类衍生物的制备方法,其特征在于,包括以下步骤:在N,N'-二环己基碳二亚胺和4-二甲胺基吡啶的作用下,辛可宁与羧酸在溶剂中进行酯化反应;所述羧酸的分子式为RCOOH,R选自烷基、苯亚烷基、萘亚烷基、苯基、取代苯基中的任一种;所述烷基中的碳原子个数为1~5;所述苯亚烷基、萘亚烷基中亚烷基的碳原子个数为1~4;所述取代苯基中的取代基为卤素、硝基、烷氧基、碳原子个数为1~4的烷基中的一种或多种,所述烷氧基中的碳原子个数为1~3。4. The preparation method of 9S-acyloxycinchonine derivatives according to any one of claims 1 to 3, characterized in that, comprising the following steps: in N,N'-dicyclohexylcarbodiimide and 4 -Under the action of dimethylaminopyridine, cinchonine and carboxylic acid are esterified in a solvent; the molecular formula of the carboxylic acid is RCOOH, and R is selected from alkyl, phenylalkylene, naphthylene, phenyl, Any of the substituted phenyl groups; the number of carbon atoms in the alkyl group is 1-5; the number of carbon atoms in the alkylene group in the phenylalkylene and naphthylene alkylene groups is 1-4; The substituents in the substituted phenyl group are one or more of halogen, nitro, alkoxy, and alkyl groups with 1 to 4 carbon atoms, and the number of carbon atoms in the alkoxy group is 1 ~3. 5.根据权利要求4所述的9S-酰氧基辛可宁类衍生物的制备方法,其特征在于,反应时,每摩尔的辛可宁对应使用(1~1.3)mol的羧酸。5 . The method for preparing 9S-acyloxycinchonine derivatives according to claim 4 , wherein, during the reaction, (1-1.3) mol of carboxylic acid is used for each mole of cinchonine. 6 . 6.一种辛可宁或如权利要求1~3任一项所述的9S-酰氧基辛可宁类衍生物在防治虫害方面的应用。6 . The application of cinchonine or the 9S-acyloxycinchonine derivative according to any one of claims 1 to 3 in controlling insect pests. 7 . 7.根据权利要求6所述的应用,其特征在于,所述防治虫害为防治鳞翅目虫害。7 . The application according to claim 6 , wherein the pest control is the control of Lepidopteran pests. 8 . 8.根据权利要求7所述的应用,其特征在于,所述鳞翅目虫害为粘虫虫害。8 . The application according to claim 7 , wherein the Lepidopteran pests are armyworm pests. 9 . 9.根据权利要求8所述的应用,其特征在于,辛可宁或9S-酰氧基辛可宁类衍生物通过诱导粘虫畸形生长实现粘虫虫害的防治。9 . The application according to claim 8 , wherein the cinchonine or 9S-acyloxycinchonine derivatives realize the control of armyworm pests by inducing abnormal growth of armyworms. 10 . 10.一种植物源杀虫剂,其特征在于,包括活性成分,所述活性成分中包括如权利要求1~3任一项所述的9S-酰氧基辛可宁类衍生物、辛可宁中的至少一种。10. A botanical insecticide, characterized in that it comprises an active ingredient comprising at least one of the 9S-acyloxycinchonine derivatives and cinchonine according to any one of claims 1 to 3. A sort of.
CN201911001699.2A 2019-10-21 2019-10-21 A kind of 9S-acyloxycinchonine derivatives and preparation method and application thereof, botanical insecticide Expired - Fee Related CN110759905B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911001699.2A CN110759905B (en) 2019-10-21 2019-10-21 A kind of 9S-acyloxycinchonine derivatives and preparation method and application thereof, botanical insecticide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911001699.2A CN110759905B (en) 2019-10-21 2019-10-21 A kind of 9S-acyloxycinchonine derivatives and preparation method and application thereof, botanical insecticide

Publications (2)

Publication Number Publication Date
CN110759905A true CN110759905A (en) 2020-02-07
CN110759905B CN110759905B (en) 2021-05-11

Family

ID=69331487

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911001699.2A Expired - Fee Related CN110759905B (en) 2019-10-21 2019-10-21 A kind of 9S-acyloxycinchonine derivatives and preparation method and application thereof, botanical insecticide

Country Status (1)

Country Link
CN (1) CN110759905B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018549A2 (en) * 2001-08-30 2003-03-06 Chemocentryx, Inc. Bicyclic compounds as inhibitors of chemokine binding to us28
WO2004092123A2 (en) * 2003-04-10 2004-10-28 Microbia, Inc. Inhibitors of fungal invasion
WO2013132058A1 (en) * 2012-03-08 2013-09-12 Julius-Maximilians-Universität Würzburg Diagnostic chewing gum for pathogens
CN105432669A (en) * 2014-08-22 2016-03-30 付顺林 Method for controlling Lepidoptera larvae with combination of Metarhizium and alkaloids
CN106106475A (en) * 2016-06-22 2016-11-16 叶松 A kind of compositions preventing and treating pears food bud moth and preparation method thereof
CN110301441A (en) * 2019-07-09 2019-10-08 云南大学 The new application of chloroquine prevention and treatment root-knot nematode

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018549A2 (en) * 2001-08-30 2003-03-06 Chemocentryx, Inc. Bicyclic compounds as inhibitors of chemokine binding to us28
WO2004092123A2 (en) * 2003-04-10 2004-10-28 Microbia, Inc. Inhibitors of fungal invasion
WO2013132058A1 (en) * 2012-03-08 2013-09-12 Julius-Maximilians-Universität Würzburg Diagnostic chewing gum for pathogens
CN105432669A (en) * 2014-08-22 2016-03-30 付顺林 Method for controlling Lepidoptera larvae with combination of Metarhizium and alkaloids
CN106106475A (en) * 2016-06-22 2016-11-16 叶松 A kind of compositions preventing and treating pears food bud moth and preparation method thereof
CN110301441A (en) * 2019-07-09 2019-10-08 云南大学 The new application of chloroquine prevention and treatment root-knot nematode

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
MAKOTO SHIMIZU ET AL.: "Switchover of the diastereofacial selectivity in the Michael reaction of a chiral ester enolate with α,β-enone", 《SYNLETT》 *
NOBUYUKI HARADA AND KOJI NAKANISHI: "Exciton chirality method and its application to configurational and conformational studies of natural products", 《ACC. CHEM. RES.》 *
TETSUSHI YAMASHITA ET AL.: "Asymmetric reactions. III. The asymmetric synthesis of methyl 2-phenylpropionate in the presence of chiral polymers", 《BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN》 *
TIBOR BART´OK ET AL.: "New results on the mass spectra of cinchona alkaloids", 《J. MASS SPECTROM.》 *
UMAR FAROOQ ET AL.: "Synthesis of new enantiomerically pure organoiodine catalysts and their application in the α-functionalization of ketones", 《SYNTHESIS》 *
刘璐 等: "贪食迈阿密虫的体外培养及有效抗虫药物筛选", 《宁波大学学报(理工版)》 *
游秀峰 等: "人类基本呈味物质对菜粉蝶幼虫的拒食作用", 《河南农业科学》 *
车志平 等: "奎宁类化合物研究进展", 《化学通报》 *

Also Published As

Publication number Publication date
CN110759905B (en) 2021-05-11

Similar Documents

Publication Publication Date Title
CN112457288B (en) Piperine acid derivative and application thereof
JPS6021574B2 (en) Novel carboxylic acids and esters
CN109678845A (en) Pyrazole amide analog derivative of the structure containing benzotriazole and its preparation method and application
CN103275094B (en) (20S)-camptothecin derivatives and application thereof
Harrison et al. 1, 3, 5‐Triazapenta‐1, 4‐dienes: Chemical aspects of a new group of pesticides
CN106432081B (en) Preparation method and application of pyrazole oxime ether compound containing 4-chloro-3-ethyl-1-methylpyrazole structure
Che et al. Synthesis of novel (9S)‐acyloxy derivatives of quinidine and dihydroquinidine as insecticidal agents
CN110590661B (en) Osthole ester derivative, and preparation method and application thereof
CN110759905A (en) 9S-acyloxy cinchonine derivative, preparation method and application thereof, and botanical pesticide
CN109053713A (en) Pyrazole Oxime Esters of the biphenyl structures containing oxazole and its preparation method and application
CN102603687B (en) Fraxinellone acylhydrazone/hydrazone/ester derivatives and application in preparation of plant source insecticides
Che et al. Combinatorial synthesis of novel 9R-acyloxyquinine derivatives as insecticidal agents
JPS5982345A (en) Cyclopropane carboxylic acid compounds having allene structure, manufacture, intermediate, use as parasiticide and composition
CN110759904B (en) 9R-acyloxy quinine derivative and preparation method thereof, application of quinine or derivative thereof, and botanical pesticide
CN110642855B (en) A kind of cinchonidine compound and its preparation method, application, insecticide
CN105037329B (en) Fluorine-containing tetrazine pyrazol acaricide
US4540710A (en) Insecticidal ester enantiomers
CN115363028A (en) Application of DMNT structure modification product as a medicine against lepidopteran pests invading crops
CN113461630A (en) Nootkatone thioether derivative containing 1,3, 4-oxadiazole ring, and preparation method and application thereof
CN110642856B (en) Dihydroquinidine compounds, preparation method and application thereof, and botanical insecticides
CN114560810A (en) C19-diterpenoid alkaloid analogue and preparation method and application thereof
CN1970535B (en) Preparation method of cycloprothrin optical activity isomer
CN114375952B (en) Application of hydroxy-alpha-sanshool in preparation of insecticide and/or antifeedant
CN107522676B (en) Preparation and Application of Cyanoacrylate Derivatives Containing Oxazole Biphenyl Sulfide Structure
CN110754474B (en) Application of quinidine or quinidine derivatives, botanical pesticide, quinidine derivatives and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Chen Genqiang

Inventor after: Che Zhiping

Inventor after: Tian Yuee

Inventor after: Liu Shengming

Inventor after: Xia Yanfei

Inventor after: Lin Xiaomin

Inventor after: Sun Di

Inventor after: Yang Jinming

Inventor before: Che Zhiping

Inventor before: Tian Yuee

Inventor before: Xia Yanfei

Inventor before: Liu Shengming

Inventor before: Chen Genqiang

Inventor before: Lin Xiaomin

Inventor before: Sun Di

Inventor before: Yang Jinming

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210511